CN112175039A - 一种绿色、广谱的蛋白质交联方法 - Google Patents
一种绿色、广谱的蛋白质交联方法 Download PDFInfo
- Publication number
- CN112175039A CN112175039A CN201911246752.5A CN201911246752A CN112175039A CN 112175039 A CN112175039 A CN 112175039A CN 201911246752 A CN201911246752 A CN 201911246752A CN 112175039 A CN112175039 A CN 112175039A
- Authority
- CN
- China
- Prior art keywords
- protein
- collagen
- cross
- linked
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 116
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title claims abstract description 51
- 238000004132 cross linking Methods 0.000 title claims abstract description 47
- 239000000463 material Substances 0.000 claims abstract description 43
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000011259 mixed solution Substances 0.000 claims abstract description 12
- 239000002131 composite material Substances 0.000 claims abstract description 5
- 108010035532 Collagen Proteins 0.000 claims description 113
- 102000008186 Collagen Human genes 0.000 claims description 113
- 229920001436 collagen Polymers 0.000 claims description 113
- 235000018102 proteins Nutrition 0.000 claims description 108
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 210000001519 tissue Anatomy 0.000 claims description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 13
- 108010076119 Caseins Proteins 0.000 claims description 13
- 108010000912 Egg Proteins Proteins 0.000 claims description 13
- 102000002322 Egg Proteins Human genes 0.000 claims description 13
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 13
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 13
- 108090000526 Papain Proteins 0.000 claims description 13
- 102000057297 Pepsin A Human genes 0.000 claims description 13
- 108090000284 Pepsin A Proteins 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 13
- 229940098773 bovine serum albumin Drugs 0.000 claims description 13
- 239000005018 casein Substances 0.000 claims description 13
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 13
- 235000021240 caseins Nutrition 0.000 claims description 13
- 235000019834 papain Nutrition 0.000 claims description 13
- 229940055729 papain Drugs 0.000 claims description 13
- 229940111202 pepsin Drugs 0.000 claims description 13
- 230000001678 irradiating effect Effects 0.000 claims description 12
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 10
- 235000014103 egg white Nutrition 0.000 claims description 10
- 210000000969 egg white Anatomy 0.000 claims description 10
- 210000000988 bone and bone Anatomy 0.000 claims description 9
- 230000008439 repair process Effects 0.000 claims description 9
- 102000011632 Caseins Human genes 0.000 claims description 7
- 239000012876 carrier material Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 230000002439 hemostatic effect Effects 0.000 claims description 7
- 238000013268 sustained release Methods 0.000 claims description 7
- 239000012730 sustained-release form Substances 0.000 claims description 7
- 102000009027 Albumins Human genes 0.000 claims description 6
- 108010088751 Albumins Proteins 0.000 claims description 6
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 239000002473 artificial blood Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 230000003592 biomimetic effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- -1 silver ions Chemical class 0.000 abstract description 8
- 239000012620 biological material Substances 0.000 abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract description 3
- 229910052709 silver Inorganic materials 0.000 abstract description 3
- 239000004332 silver Substances 0.000 abstract description 3
- 231100000481 chemical toxicant Toxicity 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 81
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(I) nitrate Inorganic materials [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 48
- 238000001514 detection method Methods 0.000 description 45
- 238000003917 TEM image Methods 0.000 description 29
- 238000001878 scanning electron micrograph Methods 0.000 description 26
- 238000002411 thermogravimetry Methods 0.000 description 13
- 101710134784 Agnoprotein Proteins 0.000 description 12
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 8
- 239000012295 chemical reaction liquid Substances 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000000825 ultraviolet detection Methods 0.000 description 7
- 238000010382 chemical cross-linking Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 210000004087 cornea Anatomy 0.000 description 5
- 239000003431 cross linking reagent Substances 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001757 thermogravimetry curve Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002188 infrared transmission spectroscopy Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (11)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911246752.5A CN112175039B (zh) | 2019-12-08 | 2019-12-08 | 一种绿色、广谱的蛋白质交联方法 |
PCT/CN2020/134395 WO2021115237A1 (zh) | 2019-12-08 | 2020-12-08 | 一种绿色、广谱的蛋白质交联方法 |
US17/782,649 US20220389052A1 (en) | 2019-12-08 | 2020-12-08 | Green and broad-spectrum protein cross-linking method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911246752.5A CN112175039B (zh) | 2019-12-08 | 2019-12-08 | 一种绿色、广谱的蛋白质交联方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112175039A true CN112175039A (zh) | 2021-01-05 |
CN112175039B CN112175039B (zh) | 2021-08-31 |
Family
ID=73918852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911246752.5A Active CN112175039B (zh) | 2019-12-08 | 2019-12-08 | 一种绿色、广谱的蛋白质交联方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220389052A1 (zh) |
CN (1) | CN112175039B (zh) |
WO (1) | WO2021115237A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507364A (zh) * | 2022-02-15 | 2022-05-17 | 浙江大学 | 光固化酪蛋白水凝胶的制法及在止血和皮肤修复上的应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113354839B (zh) * | 2020-08-26 | 2022-08-23 | 胶原蛋白(武汉)生物科技有限公司 | 一种胶原蛋白-银纳米粒子复合凝胶、制备方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102698313A (zh) * | 2012-01-11 | 2012-10-03 | 北京大学 | 一种纳米银抗菌水凝胶及其制备方法 |
CN104857551A (zh) * | 2015-06-18 | 2015-08-26 | 中国医学科学院生物医学工程研究所 | 一种含银抗菌敷料及制备方法 |
WO2016028238A1 (en) * | 2014-08-22 | 2016-02-25 | Koç Üniversitesi | A ph responsive hybrid hydrogel and method of synthesis thereof |
CN110452413A (zh) * | 2019-07-08 | 2019-11-15 | 南京中富先农生物科技有限公司 | 一种胶原蛋白交联剂组合物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9155799B2 (en) * | 2012-11-19 | 2015-10-13 | Mimedx Group, Inc. | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent |
WO2017139102A1 (en) * | 2016-02-11 | 2017-08-17 | Lifecell Corporation | Methods for stabilizing collagen-containing tissue products against enzymatic degradation |
CN108752604B (zh) * | 2018-06-07 | 2021-02-02 | 北京大清生物技术股份有限公司 | 一种软组织填充材料及其制备方法与应用 |
-
2019
- 2019-12-08 CN CN201911246752.5A patent/CN112175039B/zh active Active
-
2020
- 2020-12-08 US US17/782,649 patent/US20220389052A1/en active Pending
- 2020-12-08 WO PCT/CN2020/134395 patent/WO2021115237A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102698313A (zh) * | 2012-01-11 | 2012-10-03 | 北京大学 | 一种纳米银抗菌水凝胶及其制备方法 |
WO2016028238A1 (en) * | 2014-08-22 | 2016-02-25 | Koç Üniversitesi | A ph responsive hybrid hydrogel and method of synthesis thereof |
CN104857551A (zh) * | 2015-06-18 | 2015-08-26 | 中国医学科学院生物医学工程研究所 | 一种含银抗菌敷料及制备方法 |
CN110452413A (zh) * | 2019-07-08 | 2019-11-15 | 南京中富先农生物科技有限公司 | 一种胶原蛋白交联剂组合物及其应用 |
Non-Patent Citations (2)
Title |
---|
HU ZHOU,ET AL.: "In-situ preparation of silver salts/collagen fiber hybrid composites and their photocatalytic and antibacterial activities", 《JOURNAL OF HAZARDOUS MATERIALS》 * |
梁淼等: "基于蛋白及其组装体的金属纳米复合材料构建", 《化工学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507364A (zh) * | 2022-02-15 | 2022-05-17 | 浙江大学 | 光固化酪蛋白水凝胶的制法及在止血和皮肤修复上的应用 |
CN114507364B (zh) * | 2022-02-15 | 2022-07-26 | 浙江大学 | 光固化酪蛋白水凝胶的制法及在止血和皮肤修复上的应用 |
Also Published As
Publication number | Publication date |
---|---|
US20220389052A1 (en) | 2022-12-08 |
WO2021115237A1 (zh) | 2021-06-17 |
CN112175039B (zh) | 2021-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69828665T2 (de) | Verfahren zur Herstellung von vernetztem Material auf Kollagenbasis und daraus hergestellte bioprothetische Vorrichtungen | |
US7163965B2 (en) | Process for producing porous composite materials | |
WO2013105665A1 (ja) | コラーゲン構造体、およびコラーゲン構造体の製造方法 | |
CN112175039B (zh) | 一种绿色、广谱的蛋白质交联方法 | |
US20030036636A1 (en) | Process for preparing porous collagen matrix from connective tissue | |
CN1711113A (zh) | 含有自体组织化磷灰石/胶原复合体的交联磷灰石/胶原多孔体及其制备方法 | |
CN103223190B (zh) | ε-聚赖氨酸-DOHA原位凝胶粘合材料及其制备方法 | |
US20090074837A1 (en) | Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite | |
EP4108265A1 (en) | Functionalized biological matrix material, preparation method therefor and use thereof | |
CN110172163A (zh) | 一种基于物理-化学双交联制备丝素蛋白-酪胺改性透明质酸水凝胶材料的方法 | |
CN115087470A (zh) | 一种功能化生物基质材料及其制备方法和应用 | |
JP5453690B2 (ja) | コラーゲン・キトサン複合繊維状多孔体及びその製造方法 | |
CN109762184B (zh) | 一种胶原蛋白水凝胶的制备方法 | |
CN109453430A (zh) | 一种羟基磷灰石涂层的胶原蛋白-氧化石墨烯仿生材料及其制备方法 | |
JPH10501706A (ja) | 細胞−ゲル | |
CN112717202A (zh) | 一种金属@茶多酚纳米颗粒自组装生物组织及其制备方法 | |
CN112940302B (zh) | 金属离子介导的胶原蛋白凝胶、制备方法及应用 | |
CN110227181A (zh) | 一种丝素蛋白复合羟基磷灰石材料的制备方法及其应用 | |
CN102757625A (zh) | 一种壳聚糖-聚乳酸多孔复合材料及其制备方法 | |
CN109337383A (zh) | 一种胶原基自修复水凝胶及其制备方法 | |
KR20130134447A (ko) | 신규한 나노섬유막 및 이의 제조방법 | |
CN107354800B (zh) | 一种基于造纸法制备具有ecm结构的人体组织代用材料的方法 | |
CN113638221B (zh) | 一种具有生物活性的聚丙烯腈纤维及其制备方法 | |
CN114870082B (zh) | 一种高强度复合胶原膜及其制备方法和应用 | |
CN117887134B (zh) | 一种水凝胶仿生矿化支架及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211011 Address after: No. 249, Donggang West Road, Chengguan District, Lanzhou City, Gansu Province 730000 Patentee after: Gansu Tianji Biotechnology Co.,Ltd. Address before: 730000 No. 222 Tianshui South Road, Chengguan District, Gansu, Lanzhou Patentee before: LANZHOU University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211102 Address after: 430030 a413, No. 74, Baofeng Second Road, Qiaokou District, Wuhan City, Hubei Province Patentee after: Collagen (Wuhan) Biotechnology Co.,Ltd. Address before: No. 249, Donggang West Road, Chengguan District, Lanzhou City, Gansu Province 730000 Patentee before: Gansu Tianji Biotechnology Co.,Ltd. |